Faculty profile

Stanley Nattel

ResearcherMedicineUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses and email address may be missing. Find their university profile.

Stanley Nattel

Researcher

Medicine

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
55 publications in the last five years, latest in 2026.
Senior (last) author on 19 recent papers, a sign of leading a research group.
Principal investigator on 5 research grants (5 CIHR), most recently in 2022.
Supervised 2 trainees who won CIHR awards, most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

345

Publications

1,067

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cardiac Fibroblasts Cardiomyocytes Electrophysiology Heart Failure Pharmacology Remodelling Atrial Fibrillation Cardiac Action Potentials

Latest papers

Left-atrial low-voltage areas and sex: mechanisms and insights into sex-related differences in atrial fibrillation susceptibility.
European heart journal · 2026 · first author
Pacemaker-implantation and atrioventricular-node ablation vs pulmonary vein isolation for elderly patients with persistent atrial fibrillation: the ABLATE versus PACE trial.
European heart journal · 2026
Clearance of p16-positive cardiac cells improves age-related cardiac remodeling in mice.
Experimental physiology · 2026 · senior author

All 345 publications

Latest funding

Role of the Calcitonin Receptor System in Cardiac Physiology and Remodeling
CIHR · 2022 · Nominated PI
$921,826
Resolving Unchecked Inflammation in Atrial Fibrillation
CIHR · 2021 · Supervisor
$105,000
Blinded Randomized trial of Anticoagulation to prevent Ischemic stroke and Neurocognitive impairment in Atrial Fibrillation study
CIHR · 2020 · Co-investigator
$1,372,410

All 15 grants and awards

From the 150 most recent of 345 publications.

Left-atrial low-voltage areas and sex: mechanisms and insights into sex-related differences in atrial fibrillation susceptibility.

Nattel S

European heart journal2026First author

DOI: 10.1093/eurheartj/ehaf767 PMID: 41217878

Pacemaker-implantation and atrioventricular-node ablation vs pulmonary vein isolation for elderly patients with persistent atrial fibrillation: the ABLATE versus PACE trial.

Boehmer AA, Eckardt L, Rothe M, Kaess BM, Doldi F, Guener F, Bogossian H, Iliodromitis K, Bastian D, Buia V, Kuniss M, Dichtl W, Wakili R, Willems S, Schumacher B, Mathew S, Ince H, Fichtner S, Leistner DM, Meyer C, Rillig A, Metzner A, Ruckes C, Tijssen JGP, Crijns HJGM, Nattel S, Ehrlich JR, “ABLATE versus PACE” Investigators

European heart journal2026

DOI: 10.1093/eurheartj/ehag742 PMID: 42671117

Clearance of p16-positive cardiac cells improves age-related cardiac remodeling in mice.

Mehdizadeh M, Mackasey M, Gharagozloo K, Aguilar M, Naud P, Ochs A, Vuong-Robillard N, Thorin E, Ferbeyre G, Tardif JC, Sirois MG, Tanguay JF, Nattel S

Experimental physiology2026Senior author

DOI: 10.1113/ep093551 PMID: 42734482

Atrial Cardiomyopathy and Atrial Fibrillation in Endurance Athletes: Differentiating Physiological Adaptation From Pathological Remodeling.

Nattel S

JACC. Clinical electrophysiology2026First author

DOI: 10.1016/j.jacep.2026.04.026 PMID: 42360260

Resistance to atrial fibrillation domestication and mitochondrial dysfunction in sheep: a potential key role of the TCA cycle and mitochondrial redox state.

Caluori G, Nattel S, Pinson B, Naud P, Beauvoit B, Claverol S, Vaillant F, Charron S, Guilloteau F, Loyer V, Constantin M, Popa M, Belykh A, Rogowsky A, Haeberlin A, Ploux S, Mahamat HA, Dubois R, Guillot B, Krisai P, Kamakura T, Bernus O, Jaïs P, Dos Santos P, Pasdois P

Redox biology2026

DOI: 10.1016/j.redox.2026.104391 PMID: 42753315

G protein-coupled receptors and inflammation resolution signaling networks in the heart: Pharmacology and potential for innovative therapeutics.

Sosnowski DK, Hébert TE, Dobrev D, Nattel S

Pharmacological reviews2026Senior author

DOI: 10.1016/j.pharmr.2026.100129 PMID: 41875505

Oxidative stress-driven transcriptomic remodeling in human astrocytes reveals network signatures associated with neurodegenerative and cardiovascular processes.

Bota PM, Picón-Pagès P, Fanlo-Ucar H, Almabhouh S, Bagudanch O, Zeylan ME, Senyuz S, Gohl P, Molina-Fernández R, Fernandez-Fuentes N, Barbu E, Vicente R, Nattel S, Ois A, Puig-Pijoan A, Garcia-Ojalvo J, Keskin O, Gursoy A, Muñoz FJ, Oliva B

Computational and structural biotechnology journal2026

DOI: 10.1016/j.csbj.2025.12.032 PMID: 41550140

Pulmonary Vein Isolation Only for Atrial Fibrillation With Heart Failure (POLAR-HF).

Boehmer AA, Rothe M, Andrade JG, Wiedenmann L, Spork P, Schneider KY, Nussbaum E, Keim C, Weiss P, Dobre BC, Feickert S, Ruckes C, Dyrda K, Kaess BM, Nattel S, Ehrlich JR

JACC. Clinical electrophysiology2026

DOI: 10.1016/j.jacep.2025.09.041 PMID: 41263723

The clinical pathophysiology of atrial fibrillation: outstanding questions from bedside to bench and back.

Boehmer AA, Ninni S, Heijman J, Dobrev D, Nattel S

Physiological reviews2026Senior author

DOI: 10.1152/physrev.00020.2025 PMID: 41543444

Selective blockade of microRNA-31-5p/calcitonin receptor interaction reverses established atrial fibrosis and atrial arrhythmia substrate.

Trompf J, Cox K, Hulsurkar M, Moreira LM, Yiu CHK, Johnston AM, Lahiri SK, Zhao S, Robinson P, Hiram R, Mehdizadeh M, Carrillo LP, Sayeed R, Krasopoulos G, Srivastava V, Walcot N, Farid S, Kourliouros A, Sastry P, Menassa DA, Davies B, Schack RA, Pautler RG, Channon KM, Lygate C, Nattel S, Wehrens XHT, Reilly S

Research square2026

DOI: 10.21203/rs.3.rs-8484728/v1 PMID: 41542044

Role of the Calcitonin Receptor System in Cardiac Physiology and Remodeling

Nominated PICIHR2022Project Grant

Principal investigators: Nattel, Stanley

Keywords: Cardiac Fibroblasts; Cardiomyocytes; Electrophysiology; Heart Failure; Pharmacology; Remodelling

$921,826

Resolving Unchecked Inflammation in Atrial Fibrillation

SupervisorCIHR2021Doctoral Research Award: Canada Graduate Scholarships

Principal investigators: Sosnowski, Deanna

Keywords: Atrial Fibrillation; Canine Atrial-Tachypacing, In Vitro Cardiomyocyte Pacing; Confocal Fluorescent Microscopy; Dog Atrial Myocytes And Fibroblasts - Primary Cell Culture; Inflammation And Innate Immune System - Nlrp3 Inflammasome; Pro-Resolving Lipid Mediators - Resolvins; Resolvin G-Protein Coupled Receptor Expression/Signalling; Viral Transduction With Shrna

$105,000

Blinded Randomized trial of Anticoagulation to prevent Ischemic stroke and Neurocognitive impairment in Atrial Fibrillation study

Co-investigatorCIHR2020Project Grant

Principal investigators: Rivard, Léna; Khairy, Paul; Roy, Denis

Keywords: Anticoagulation; Atrial Fibrillation; Cognition; Stroke

$1,372,410

Cell specific functions of Lysyl oxidases in the heart.

SupervisorCIHR2018CIHR Fellowship

Principal investigators: Takawale, Abhijit R

Keywords: Cardiac Fibroblast; Cardiac Fibrosis; Cardiac Myocytes; Heart Diseases; Lysyl Oxidase; Transgenic Mice

$135,000

Extracellular vesicle-based therapy for atrial fibrillation

Co-investigatorCIHR2018Project Grant

Principal investigators: Davis, Darryl R

Keywords: Atrial Fibrillation; Extracellular Vesicles

$378,675

Role of shugoshin-like 1 (SGOL1) in heart development

Co-investigatorCIHR2016Project Grant

Principal investigators: Andelfinger, Gregor U

Keywords: Arrhythmias; Heart Development; Transcriptional Regulation

$967,095

Molecular determinants of atrial fibrillation susceptibility and progression.

Nominated PICIHR2015Foundation Grant

Principal investigators: Nattel, Stanley

Keywords: Atrial Fibrillation; Cardiac Action Potentials; Cardiac Antiarrhythmic Drugs; Cardiac Calcium Handling; Cardiac Electrophysiology; Cardiac Ion Channels; Cardiovascular Pharmacology; Fibrosis; Heart Disease Treatments; New Cardiac Arrhythmia Therapy Targets

$4,422,978

Genetic and functional dissection of a novel pacemaking syndrome: a model for SGOL1 mutations

Co-investigatorCIHR2013Operating Grant

Principal investigators: Andelfinger, Gregor U

Keywords: Animal Models Of Disease; Cardiac Development; Cardiovascular Genetics; Cell Culture Techniques; Electrophysiology; Expression Analysis; Proteomics; Transcriptomics

$659,804

Mechanisms and consequences of atrial ionic remodeling

Nominated PICIHR2011Operating Grant

Principal investigators: Nattel, Stanley

Keywords: Antiarrhythmic Drugs; Atrial Fibrillation; Fibroblasts; Ion Channels; Molecular Biology; Remodeling; Whole Animal Electrophysiology

$1,126,252

Mechanisms underlying atrial fibrillation in animal models

Nominated PICIHR2010Operating Grant

Principal investigators: Nattel, Stanley

Keywords: Antiarrhythmic; Atrial Fibrillation; Atrial Remodeling; Cardiac Arrhythmias; Cardiac Conduction; Cardiac Electrophysiology

$1,084,001

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Stanley Nattel

Research

Latest papers

Latest funding

Left-atrial low-voltage areas and sex: mechanisms and insights into sex-related differences in atrial fibrillation susceptibility.

Pacemaker-implantation and atrioventricular-node ablation vs pulmonary vein isolation for elderly patients with persistent atrial fibrillation: the ABLATE versus PACE trial.

Clearance of p16-positive cardiac cells improves age-related cardiac remodeling in mice.

Atrial Cardiomyopathy and Atrial Fibrillation in Endurance Athletes: Differentiating Physiological Adaptation From Pathological Remodeling.

Resistance to atrial fibrillation domestication and mitochondrial dysfunction in sheep: a potential key role of the TCA cycle and mitochondrial redox state.

G protein-coupled receptors and inflammation resolution signaling networks in the heart: Pharmacology and potential for innovative therapeutics.

Oxidative stress-driven transcriptomic remodeling in human astrocytes reveals network signatures associated with neurodegenerative and cardiovascular processes.

Pulmonary Vein Isolation Only for Atrial Fibrillation With Heart Failure (POLAR-HF).

The clinical pathophysiology of atrial fibrillation: outstanding questions from bedside to bench and back.

Selective blockade of microRNA-31-5p/calcitonin receptor interaction reverses established atrial fibrosis and atrial arrhythmia substrate.

Frequent collaborators

Laurent Macle

Paul Khairy

Jean-Claude Tardif

Jean-Claude Tardif

Denis Roy

Denis Roy

Brett Burstein

Brett Burstein

Rafik Tadros

Léna Rivard

Jeff Healey

Judith Brouillette

Eric Thorin

Ratika Parkash

Julia Cadrin-Tourigny

Eric Thorin

Guillaume Lettre

David Gladstone

Gerardo Ferbeyre

Atul Verma

Paul Dorian

Kumaraswamy Nanthakumar

Mukul Sharma

Gregor Andelfinger

Gerardo Ferbeyre

Jason Andrade

Teresa Tsang

Anil Nigam

Louis Bherer

Maxime Tremblay-Gravel

David Conen

Jason Roberts

Jorge Wong

Gregory Curnew

Amritanshu Pandey

Clare Atzema

Sylvain Lanthier

Louise Pilote

Marc Deyell

Louis Bherer